SavedAdd your journal

Journals / Zeynep Kamil Tıp Bülteni / 2018 / Cilt: 49 - Sayı: 1

COMPARISON OF SCREENING AND TREATMENT PROTOCOLS OF SEXUALLY TRANSMITTED DISEASES

CİNSEL YOLLA BULAŞAN HASTALIKLARIN TARANMASI VE TEDAVİ PROTOKOLLERİNİN KARŞILAŞTIRILMASI

Savaş KANBUR
Pages
15–20
Publication Date
2018-03-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this cross-sectional study, having information on the frequency of sexually transmitted diseases in Turkey indirectly and comparison of treatment options are aimed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vulvovaginal complaints are one of the top reasons for applying to medical institutions in women.
📊
Key Findings & Data:Gonorrhoeae, Syphilis make up 80% of the total vulvovaginal diseases.
💡
Conclusion & Impact:In this cross-sectional study, having information on the frequency of sexually transmitted diseases in Turkey indirectly and comparison of treatment options are aimed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Cinsel yolla bulaşan hastalıklar · Jinekoloji · Vulvovajinal enfeksiyonlar

Abstract

Vulvovaginal complaints are one of the top reasons for applying to medical institutions in women. Vulvovaginal infections also take an important place in chief complaints in sexually transmitted diseases in women. Sexually transmitted diseases can cause permanent reproductive health problems in women. This situation shows the importance of the fact that sexually transmitted diseases must be diagnosed in patient population who apply to medical institutions with vulvovaginal infection symptoms. Today bacterial, parasitic and fungal vulvovaginal infection causes like Candida Albicans, Gardnerella Vaginalis, Trichomonas Vaginalis, N. Gonorrhoeae, Syphilis make up 80% of the total vulvovaginal diseases. In this cross-sectional study, having information on the frequency of sexually transmitted diseases in Turkey indirectly and comparison of treatment options are aimed.

Özet

Kadınlarda vulvovajinal yakınmalar sağlık kuruluşlarına başvurma sebepleri arasında ilk sıralarda yer almaktadır.Vulvovajinal enfeksiyonlar, ayrıca kadınlarda cinsel yolla bulaşan hastalıkların başvuru şikayetleri arasında da önemli bir yer tutmaktadır. Cinsel yolla bulaşan hastalıklar kadınlarda kalıcı üreme sağlığı problemlerine sebep olabilirler. Bu durum vulvovajinal enfeksiyon bulgularıyla sağlık kuruluşlarına gelen hasta popülasyonunda cinsel yolla bulaşan hastalıkların mutlaka ortaya çıkarılması konusundaki önemi göstermektedir. Günümüzde vulvovajinal enfeksiyon sebebi olan Kandida Albikans, Gardnarella Vajinalis, Trichomonas Vajinalis, N.Gonore ve Sifiliz gibi bakteriyel, parazitel yada mantarlara bağlı nedenler toplam vulvovajinal enfeksiyonların %80’ini oluşturmaktadır. Yapılan bu kesitsel araştırma ile indirekt yoldan Türkiye’deki cinsel yollardan bulaşan hastalıkların sıklığı ile ilgili bilgi sahibi olunması ve tedavi seçeneklerinin karşılaştırılması amaçlanmıştır.

🔖

Cite This Article

KANBUR, S. (2018). COMPARISON OF SCREENING AND TREATMENT PROTOCOLS OF SEXUALLY TRANSMITTED DISEASES. Zeynep Kamil Tıp Bülteni, Cilt: 49 - Sayı: 1, 15–20. https://ajindex.com/articles/725451

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Bakterial vaginosis: review of treatment options and potential clinical indications for therapy. Clinical Infectious Diseases. 20 Suppl l:S72-9, 1995 Apr. Value of the score for Gram stains in the diagnosis of bacterial vaginosis. Pathologie Biologie. 42(5):539-43, 1994 May. Diagnosis and prevalence of bacterial vaginosis. Journal of Postgraduate Medicine. 39(2):3, 1993 Apr-Jun. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstetrica et Gynecologica Scandinavica. 72(1):17-9, 1993 Jan. Economical treatment of bacterial vaginosis. Japanese Journal of Antibiotics. 48(3):432-6, 1995 Mar. Diagnosis of bacterial vaginosis in a routine diagnostic laboratory. Medical Laboratory Sciences. 49(1):8-11, 1992 Mar. Risk factors for gonorrhea, syphilis and trichomonas infections among women attending family planning clinics in Nairobi, Kenya. Genitourinary Medicine 70 (3):155-61, 1994 Jun. A double-blind placebo-controlled trial of single-dose intravaginal versus single-dose oral metronidazole in the treatment of trichomonal vaginitis. Journal of Infectious Diseases. 170(1):242-6, 1994 Jul. Jinekoloji polikliniğine başvuran kadınlarda Trichomonas vaginalis araştırılması. Mikrobiyoloji Bülteni. 27(4):357-63, 1993 Oct. Evaluation of new anti-infective drugs for the treatment of vaginal infections. Infectious Diseases Society of America and the Food and Dug Administration. Clinical Infectious Diseases. 15 Suppl 1:S115-22, 1992 Nov. Treatment options for vulvovaginal candidiasis, 1993 Review. Clinical Infectious Diseases. 20 Suppl 1:S80-90, 1995 Apr. Neotran - a new double - active pessary for the treatment of vaginitis. Journal of International Medical Research. 21(1): 36 -46, 1993 Jan - Feb Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis Obstetrics and Gynecology. 81(5(Pt l)): 721 - 7, 1993 May The epidemiology of vulvovaginal candidiasis among university students. American Journal ofPublic Health. 85(8 Ptl):1146-8,1995 Aug. Topical antifungal agents. Review Obstetrics and Gynecology Clinics of North America. 19(3):587- 607, 1992
  2. Sep. Blackwell AL, Fox AR, Phillips I, et al: Anaerobic vaginosis (nonspecific vaginosis): Clinical, microbiological and therapeutic findings. Lancet 2:1379-1382, 1982.
  3. Spiegel CA, Amsel R, Eschenbach DA, et al: Anaerobic bacteria in nonspecific vaginitis. N England J Med 303:601 - 607, 1980.
  4. Spiegel CA, Amsel R, Eschenbach DA, et al: Anaerobic bacteria in nonspecific vaginitis. N England J